TERUMO CORP (TRUMF:OTCMKTS)
$14.88 0.5 (3.4771%)
Analysed TERUMO CORP (TRUMF:OTCMKTS) News Sources
Geisinger and Terumo Neuro Advance Stroke Education and Neurovascular Innovation in Recognition of World Stroke Day 2025
29-10-2025
yahoo.com
OrganOx Completes Acquisition by Terumo Corporation to Advance the Future of Organ Transplantation
30-10-2025
yahoo.com
Santersus AG Completes Series A Financing and Announces Strategic Collaboration with Terumo Corporation
01-12-2025
yahoo.com
Terumo Record Q3 Highlights OrganOx Integration And Margin Story For Investors
17-02-2026
yahoo.com
Q-Sera announces the first launch of blood collection tubes using its patented Rapclot technology in Japan, opening opportunities for additional global partnerships
19-02-2026
yahoo.com
Terumo Corp (TRUMF) (Q1 2027) Earnings Call Highlights: Record Revenue and Profit Surge on ...
11-08-2026
yahoo.com
NICE Supports Routine NHS Funding and Access to Ex-Situ Machine Perfusion in a Major Step Forward for Liver Transplantation
21-08-2026
yahoo.com
4 Medical Products Stocks Poised to Win Despite Industry Headwinds
20-07-2026
yahoo.com
Zacks Industry Outlook Highlights Terumo, QuidelOrtho, Lumexa Imaging and Brainsway
21-07-2026
yahoo.com
What is the current price of TERUMO CORP (TRUMF:OTCMKTS)?
The current price of TERUMO CORP (TRUMF:OTCMKTS) is $14.88.
TERUMO CORP (TRUMF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of TERUMO CORP (TRUMF:OTCMKTS) since the previous trading day is $0.5.
TERUMO CORP (TRUMF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of TERUMO CORP (TRUMF:OTCMKTS) since the previous trading day is 3.4771%.
What is the most recent average sentiment score for TERUMO CORP (TRUMF:OTCMKTS)?
The most recent average sentiment score for TERUMO CORP (TRUMF:OTCMKTS) is 79 out of 100.
What is the most recent average sentiment for TERUMO CORP (TRUMF:OTCMKTS)?
The most recent sentiment for TERUMO CORP (TRUMF:OTCMKTS) is .
SEC-8K** Filing Available For TERUMO CORP (TRUMF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.